Novel Mechanism of Resistance to Folate Analogues: Ribonucleoside Diphosphate Reductase Deficiency in Bacteriophage T4
AUTOR(ES)
Johnson, James Robert
RESUMO
Some spontaneously occurring bacteriophage T4 mutants (far mutants) were able to form plaques in the presence of concentrations of folate analogues that completely inhibit plaque formation by wild-type phage T4. Some of these far mutants were shown to be ribonucleoside diphosphate (RDP) reductase (EC 1.17.4.1) deficient, and some independently isolated RDP reductase-deficient mutants (nrd mutants) were shown to be folate analogue resistant. The map positions of the RDP reductase-deficient far mutants were shown to be within the genes controlling the phage-induced RDP reductase activity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=429517Documentos Relacionados
- Mutants of bacteriophage T4 unable to induce dihydrofolate reductase activity.
- Bacteriophage T4 Virion Dihydrofolate Reductase: Approaches to Quantitation and Assessment of Function
- Tandem cloning of bacteriophage T4 nrdA and nrdB genes and overproduction of ribonucleoside diphosphate reductase (alpha 2 beta 2) and a mutationally altered form (alpha 2 beta 2(93)).
- Bacteriophage T4 Virion Baseplate Thymidylate Synthetase and Dihydrofolate Reductase
- Partial Suppression of Bacteriophage T4 Ligase Mutations by T4 Endonuclease II Deficiency: Role of Host Ligase 1